Style | Citing Format |
---|---|
MLA | Hedayat K, Ehsani AH. "A Phase Iii Clinical Study of the Efficacy and Safety of Botulinum Toxin Type a (Masport) With Dysport for the Treatment of Glabellar Lines." Aesthetic Plastic Surgery, vol. 48, no. 3, 2024, pp. 324-332. |
APA | Hedayat K, Ehsani AH (2024). A Phase Iii Clinical Study of the Efficacy and Safety of Botulinum Toxin Type a (Masport) With Dysport for the Treatment of Glabellar Lines. Aesthetic Plastic Surgery, 48(3), 324-332. |
Chicago | Hedayat K, Ehsani AH. "A Phase Iii Clinical Study of the Efficacy and Safety of Botulinum Toxin Type a (Masport) With Dysport for the Treatment of Glabellar Lines." Aesthetic Plastic Surgery 48, no. 3 (2024): 324-332. |
Harvard | Hedayat K, Ehsani AH (2024) 'A Phase Iii Clinical Study of the Efficacy and Safety of Botulinum Toxin Type a (Masport) With Dysport for the Treatment of Glabellar Lines', Aesthetic Plastic Surgery, 48(3), pp. 324-332. |
Vancouver | Hedayat K, Ehsani AH. A Phase Iii Clinical Study of the Efficacy and Safety of Botulinum Toxin Type a (Masport) With Dysport for the Treatment of Glabellar Lines. Aesthetic Plastic Surgery. 2024;48(3):324-332. |
BibTex | @article{ author = {Hedayat K and Ehsani AH}, title = {A Phase Iii Clinical Study of the Efficacy and Safety of Botulinum Toxin Type a (Masport) With Dysport for the Treatment of Glabellar Lines}, journal = {Aesthetic Plastic Surgery}, volume = {48}, number = {3}, pages = {324-332}, year = {2024} } |
RIS | TY - JOUR AU - Hedayat K AU - Ehsani AH TI - A Phase Iii Clinical Study of the Efficacy and Safety of Botulinum Toxin Type a (Masport) With Dysport for the Treatment of Glabellar Lines JO - Aesthetic Plastic Surgery VL - 48 IS - 3 SP - 324 EP - 332 PY - 2024 ER - |